drugset / Trial / NCT03359395

Pre-medication With Alfentanil vs Placebo During ECT

NCT03359395

Phase 4 Completed 100 enrolled Wake Forest University Health Sciences
RandomizedCrossoverDouble-blindTreatment

Summary

Hemodynamic changes associated with the conduct of electroconvulsive therapy may be minimized with the administration of alfentanil as part of their anesthetic regimen. This study proposes to compare the effects in a blinded fashion. Currently alfentanil is an FDA approved drug used on a daily basis by anesthesiologists on other surgeries so this is not a new indication.

Timeline

Start
2018-06-04
Primary completion
2020-02-17
Completion
2020-02-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator Alfentanil Other / unclassified 20 ug/kg

Indications